Form D Explorer

Form D — Liminatus Pharma, Inc.

0001104659-26-075732 · filed Jun 18, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
06b
Reported offering amount
$1,861,920
Reported amount sold
$1,861,920
Minimum investment
$0
Investors
1
Sales commission
$148,954
Finders' fees
$0

Issuer

Name
Liminatus Pharma, Inc.
CIK
1971387
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
2251 STERN GOODMAN STREET, SUITE E
FULLERTON, CA 92833
Phone
213-273-5453

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗